Search hospitals > Massachusetts > Worcester
Novo Nordisk Investigational Site
Claim this profileWorcester, Massachusetts 01605
Conducts research for Diabetes
Conducts research for Type 2 Diabetes
Conducts research for Type 1 Diabetes
Conducts research for Pituitary Dwarfism
Conducts research for Growth Hormone Disorder
15 reported clinical trials
0 medical researchers
Summary
Novo Nordisk Investigational Site is a medical facility located in Worcester, Massachusetts. This center is recognized for care of Diabetes, Type 2 Diabetes, Type 1 Diabetes, Pituitary Dwarfism, Growth Hormone Disorder and other specialties. Novo Nordisk Investigational Site is involved with conducting 15 clinical trials across 17 conditions. There are 0 research doctors associated with this hospital, such as .Top PIs
Clinical Trials running at Novo Nordisk Investigational Site
Turner Syndrome
Noonan Syndrome
Syndrome
Small for Gestational Age, Turner Syndrome, Noonan Syndrome, Intrauterine Growth Restriction.
Somapacitan vs Norditropin
for Growth Disorders
This trial compares two growth hormone treatments for children with growth issues. Somapacitan is a new treatment, while Norditropin® is an existing treatment. The study aims to find out which treatment helps these children grow better. Somapacitan is a long-acting growth hormone derivative in development for treatment of GH deficiency.
Recruiting3 awards Phase 311 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Novo Nordisk Investigational Site?
Novo Nordisk Investigational Site is a medical facility located in Worcester, Massachusetts. This center is recognized for care of Diabetes, Type 2 Diabetes, Type 1 Diabetes, Pituitary Dwarfism, Growth Hormone Disorder and other specialties. Novo Nordisk Investigational Site is involved with conducting 15 clinical trials across 17 conditions. There are 0 research doctors associated with this hospital, such as .